Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;21(4):432-444.
doi: 10.1007/s12017-019-08563-5. Epub 2019 Sep 5.

Bridging the Gap Between Diabetes and Stroke in Search of High Clinical Relevance Therapeutic Targets

Affiliations
Review

Bridging the Gap Between Diabetes and Stroke in Search of High Clinical Relevance Therapeutic Targets

Thierry Coppola et al. Neuromolecular Med. 2019 Dec.

Abstract

Diabetes affects more than 425 million people worldwide, a scale approaching pandemic proportion. Diabetes represents a major risk factor for stroke, and therefore is actively addressed for stroke prevention. However, how diabetes affects stroke severity has not yet been extensively considered, which is surprising given the evident but understudied common mechanistic features of both pathologies. The increase in number of diabetic people, incidence of stroke in the presence of this specific risk factor, and the exacerbation of ischemic brain damage in diabetic conditions (at least in animal models) warrants the need to integrate this comorbidity in preclinical studies of brain ischemia to develop novel therapeutic approaches. Therefore, a better understanding of the commonalties involved in the course of both diseases would offer the promise of discovering novel neuroprotective pathways that would be more appropriated to clinical scenarios. In this article, we will review the relevant mechanisms that have been identified as common traits of both pathologies and that could be, to our knowledge, potential targets in both pathologies.

Keywords: Comorbidity; Glucolipotoxicity; Hyperglycemia; Signaling pathways; Tolerance to brain ischemia.

PubMed Disclaimer

References

    1. Diabetes Care. 2014 Jan;37 Suppl 1:S81-90 - PubMed
    1. Hypertension. 2003 Dec;42(6):1206-52 - PubMed
    1. J Clin Invest. 2006 Jul;116(7):1793-801 - PubMed
    1. J Neurosci. 2001 Jul 1;21(13):4668-77 - PubMed
    1. Neuroscientist. 2003 Feb;9(1):10-22 - PubMed

Publication types

MeSH terms

LinkOut - more resources